Conference Overview

April 8-10, 2022

Great Debates in Cardiometabolic Medicine:

CMHC Spring 2022

The Westin Kierland Resort & Spa
6902 East Greenway Parkway
Scottsdale, AZ 85254

Add to Calendar

Days

Hours

Minutes

Seconds

World-renowned experts will present on the latest developments in cardiovascular disease, chronic kidney disease, obesity & lifestyle, type 2 diabetes, lipids, and more.

The meeting will include extensive expert panel discussions and debates, as well as ample opportunities for audience Q & A, with the goal of enhancing the interactions with thought leaders and to help clinicians walk away with practical advice to apply directly to patient care.

What to Expect

Highlighting the most current, relevant, and applicable education in the field, this conference allows attendees to learn specific strategies to combat the growing epidemic of cardiometabolic risk and disease.

Access the Latest Clinical Education

Through three days of comprehensive clinical education in cardiometabolic health, attendees will have the opportunity to learn the latest data and expert perspectives to improve patient care across several disease areas, including obesity, lifestyle medicine, diabetes, cardiovascular disease, and cardiorenal risk.

Hear From World-Renowned Faculty, Clinicians, & Speakers

Each lecture & session at CMHC is carefully curated and planned by our faculty, including a panel of Chairpersons that represent the most respected & renowned leaders in the field.

Network & Socializing Opportunities with Peers

Develop new connections with like-minded peers through numerous networking opportunities designed to foster engaging social environments.

Interactive Learning with World Renowned Faculty Members

Engage directly with a multitude of leaders who are shaping the field of cardiometabolic medicine.

Conference Chairs & SPC

Christie M. Ballantyne, MD

Cardiologist

Keith C. Ferdinand, MD

Conference Faculty

Michael J. Wilkinson, MD

Cardiologist and Lipidologist

Debbie L. Cohen, MD

Nephrologist

Fatima Cody Stanford, MD, MPH, MPA, MBA, FAAP, FACP, FAHA, FAMWA, FTOS

Obesity Medicine

Steven J. Russell, MD, PhD

Endocrinologist

Maya Vadiveloo, PhD, RD

Nutritional Epidemiologist

Athena Philis-Tsimikas, MD

Endocrinologist

Holly R. Wyatt, MD

Endocrinologist

Karol E. Watson, MD, PhD

Cardiologist

Salim S. Virani, MD, PhD

Cardiologist

Katherine R. Tuttle, MD

Robert S. Rosenson, MD

Cardiologist

Ileana L. Piña, MD, MPH

Cardiologist

Rajiv Agarwal, MD, MS

Nephrologist

Leigh Perreault, MD

Endocrinology, Diabetes and Metabolism

Alanna A. Morris, MD, MSc

Cardiologist

Michael Miller, MD, FACC, FAHA

Cardiologist

Erin D. Michos, MD, MHS

Cardiologist

Roxana Mehran, MD

Interventional Cardiologist

David S. Ludwig, MD, PhD

Endocrinologist

Lawrence A. Leiter, MD

Endocrinologist

Mikhail N. Kosiborod, MD

Cardiologist

John M. Jakicic, PhD

Obesity, Physical Activity, and Chronic Diseases Investigator

Nihar R. Desai, MD, MPH

Monica Aggarwal, MD, FACC

Integrative Cardiologist

Conference Agenda

TIME	SESSION
7:00 AM – 8:30 AM	CME Breakfast Symposium Bridging the Frontiers of Care in Patients with Type 2 Diabetes and Chronic Kidney Disease: Interpreting the Data with Novel MR Antagonists to Improve Cardiorenal Outcomes George L. Bakris, MD (Chair); Rajiv Agarwal, MD; Katherine R. Tuttle, MD Supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc.
	OPENING REMARKS & SESSION I: CARDIO-RENAL
8:30 AM	Chair Introduction George L. Bakris, MD
8:30 AM – 9:15 AM	Outcomes Trials in Chronic Kidney Disease Rajiv Agarwal, MD; Katherine R. Tuttle, MD I. Improving Renal Outcomes with SGLT-2 Inhibitors and GLP-1 RAs: Data, Interpretations, and Future Outlook II. CKD Challenging Case & Expert Panel Discussion
9:15 AM – 9:30 AM	Mini Break
9:30 AM – 11:00 AM	Outcomes Trials in Heart Failure I. SGLT-2is and ARNI Across the HF Spectrum – Alanna A. Morris MD II. New and Emerging Treatment Targets in Heart Failure – Ileana L Piña, MD III. ATTR-CM in African Americans: Advances in Diagnosis and Treatment to Help Reduce Disparities and Improve Outcomes This session is supported in part by an educational grant from Alnylam Pharmaceuticals, Inc. Keith C. Ferdinand, MD IV. HF Challenging Cases & Expert Panel Discussion
11:00 AM – 11:45 AM	Emerging Developments in Hypertension I. Emerging Treatments for Hypertension – Keith C. Ferdinand, MD II. Resistant Hypertension: Old and New – Debbie Cohen, MD III. Expert Panel Discussion & Audience Q & A
11:45 AM – 12:15 PM	Morning Break & Exhibits
12:15 PM – 1:15 PM	PME Lunch Symposium A Treatment Option for Patients With HFrEF Following a Worsening HF Event Matthew J. Budoff, MD Sponsored by Merck Sharp and Dohme Corp.
1:15 PM – 1:45 PM	Break & Exhibits
	KEYNOTE ADDRESS
1:45 PM – 2:30 PM	Cardiometabolic Centers of Excellence – a novel care delivery model to improve quality and outcomes in cardiometabolic disease Mikhail N. Kosiborod, MD
	SESSION II: DIABETES MANAGEMENT
2:30 PM	Chair Introduction Anne L. Peters, MD
2:30 PM – 2:50 PM	Prediabetes: Screening, Diagnosis, and Management Leigh Perreault, MD
2:50 PM – 3:25 PM	Continuous Glucose Monitoring: Going Beyond HbA1c to Optimize and Individualize the Management of Type 2 Diabetes This session is supported by Abbott Diabetes. Viral Shah, MD
3:25 PM – 3:45 PM	Dual GLP-1/GIP Agonists: Are They the Next Big Thing in Diabetes Treatment? Athena Philis-Tsimikas, MD
3:45 PM – 4:00 PM	Afternoon Break & Exhibits
4:00 PM – 4:20 PM	How Can We Converge the Glucocentric and Cardio-Renal Risk Management in Diabetes Patients? Lawrence A. Leiter MD
4:20 PM – 4:40 PM	The Evolution of Insulin: A 2022 Update Grazia Aleppo, MD, FACE, FACP
4:40 PM – 5:00 PM	Technology in Diabetes Beyond CGM Steven J. Russell MD, PhD
5:00 PM – 5:30 PM	Expert Panel Discussion & Audience Q & A Moderator: Anne L. Peters, MD Panelists: Viral Shah, MD ; Athena Philis-Tsimikas, MD; Lawrence A. Leiter MD; Grazia Aleppo, MD, FACE, FACP; Steven J. Russell MD, PhD
5:30 PM	Closing Remarks Anne L. Peters, MD
5:30 PM – 6:30 PM	Opening Reception

TIME	SESSION
7:30 AM – 8:30 AM	CME Breakfast Symposium The Evolving Landscape of LDL-C Reduction in High-Risk Patients: Optimizing Combination Therapy to Reduce ASCVD Risk Christie M. Ballantyne, MD (Chair); Nihar R. Desai, MD; Erin D. Michos, MD; Robert S. Rosenson, MD Supported by an educational grant from Novartis Pharmaceuticals Corporation.
	SESSION III: OBESITY AND LIFESTYLE MEDICINE
8:30 AM – 8:35 AM	Chair Introduction and Opening Remarks Robert H. Eckel, MD
8:35 AM – 9:35 AM	Lifestyle Approaches to Target Obesity & Cardiometabolic Risk I. Physical Activity – John Jakicic, PhD II. Nutrition and Cardiometabolic Risk – Maya Vadiveloo, PhD, RD III. Motivational Interviewing and Behavioral Strategies to Address Weight Management – Holly R. Wyatt, MD
9:35 AM – 9:55 AM	The Evolving Landscape of NAFLD and NASH Kenneth Cusi, MD
9:55 AM – 10:35 AM	To Be Resolved: Which Approach is Better for Weight Loss? I. Medical Management – Holly R. Wyatt, MD II. Metabolic Surgery – Donna H. Ryan, MD III. Clinical Implications: Expert Discussions & Audience Q/A
10:35 AM – 11:05 AM	Morning Break & Exhibits
11:05 AM – 11:25 AM	Addressing Bias, Stigma & Racial Disparities in Obesity Care Fatima C. Stanford, MD
11:25 AM – 12:05 PM	Challenging Cases & Expert Panel Discussion Moderator: Robert H. Eckel, MD Panelists: John Jakicic, PhD; Maya Vadiveloo, PhD, RD; Holly R. Wyatt, MD; Fatima C. Stanford, MD; Donna H. Ryan, MD
12:05 PM – 12:10 PM	Closing Remarks Robert H. Eckel, MD
12:10 PM – 12:25 PM	Break
12:25 PM – 1:25 PM	CME Lunch Symposium Changing The Treatment Paradigm for LDL-C Lowering Post-MI: The Case for Early, ‘High-Intensity Lipid Lowering Therapy’ to Improve Outcomes Christie M. Ballantyne, MD (Chair); Salim S. Virani, MD, Pam R. Taub, MD This activity is supported by educational funding provided by Amgen.
1:25 PM – 1:40 PM	Break
	SESSION IV: DYSLIPIDEMIA/ATHEROSCLEROSIS/THROMBOSIS
1:40 PM – 1:45 PM	Chair Introduction Christie M. Ballantyne, MD
1:45 PM – 2:05 PM	ASCVD Risk Assessment and Prevention: Where Do We Stand Now? Salim S. Virani, MD
2:05 PM – 2:25 PM	LDL-C-Lowering Therapies: New Approaches to Address Old Challenges Pam R. Taub, MD
2:25 PM – 2:45 PM	Lp(a) and Cardiovascular Risk Michael Wilkinson, MD
2:45 PM – 3:15 PM	Afternoon Break & Exhibits
3:15 PM – 3:35 PM	What’s the Scoop with Triglycerides and ASCVD Risk? Karol E. Watson, MD
3:35 PM – 3:55 PM	The Spectrum of Familial Hypercholesterolemia Robert S. Rosenson, MD
3:55 PM – 4:15 PM	Updates in Antithrombotic Therapy for the Cardiometabolic Patient Roxana Mehran, MD
4:15 PM – 5:00 PM	Challenging Cases & Expert Panel Discussion and Q&A Moderator: Christie M. Ballantyne, MD Panelists: Robert H. Eckel, MD; Salim S. Virani, MD; Pam R. Taub, MD; Michael Wilkinson, MD; Karol E. Watson, MD; Robert S. Rosenson, MD; Roxana Mehran, MD
5:00 PM	Closing Remarks Christie M. Ballantyne, MD
5:00 PM – 6:00 PM	Happy Hour & Giveaways

TIME	SESSION
7:30 AM – 8:00 AM	Breakfast
	GREAT DEBATES IN CARDIOMETABOLIC MEDICINE
8:00 AM – 8:05 AM	Introduction and Opening Remarks Christie M. Ballantyne, MD
8:05 AM – 9:05 AM	Do patients benefit from Omega-3 Fatty Acids for CVD Prevention? Christie M. Ballantyne, MD; Michael Miller, MD; Karol E. Watson, MD I. Yes II. No III. Expert Discussions & Audience Q/A
9:05 AM – 10:05 AM	What is the Standard of Care for Heart Failure with Preserved Ejection Fraction (HFpEF)? Ileana L Piña, MD; Mikhail N. Kosiborod, MD; Alanna A. Morris, MD I. SGLT-2 Inhibitors II. ARNI and Others III. Expert Discussions & Audience Q/A
10:05 AM – 10:20 AM	Mini-Break
10:20 AM – 11:20 AM	Drawing The Line Between Primary and Secondary Cardiovascular Prevention: Essential or Too Simplistic?. Christie Ballantyne, MD; Pam R. Taub, MD; Salim S. Virani, MD I. Essential II. Too Simplistic III. Expert Discussions & Audience Q/A
11:20 AM – 12:20 PM	The Plate Debate: Which Approach is Better for the Management of Obesity and Cardiometabolic Risk? Robert H. Eckel, MD; Monica Aggarwal, MD; David Ludwig, MD; Holly R. Wyatt, MD I. Plant-based diets II. Low-carb diets III. It’s more complex than that IV. Expert Discussions & Audience Q/A
12:20 PM – 12:30 PM	Closing Remarks Christie M. Ballantyne, MD

Event Registration

We are pleased to announce that all CME sessions from this conference will be available for complimentary on-demand viewing and CE credit until 4/10/23. This virtual add-on is included with your event registration and allows our in-person audience to experience session highlights from home for up to one year after the meeting concludes.

	REGISTER BY: 3/31/2022	REGISTER BY: 4/8/2022
Physicians		$395
Allied Health Professionals		$295
Fellows / Residents / Students*		Complimentary
Industry		$495

Slide table to see all pricing options

*Must submit proof of residency, fellowship or student ID

Conference Venue

Join us at The Westin Kierland Resort & Spa

Attendees will receive the conference group rate of $295 + tax per room, per night. The group rate is guaranteed for reservations made on or before March 16, 2022, or until the CMHC room block is filled. When booking, mention group code CMHC

Conference Venue

The Westin Kierland Resort & Spa

6902 East Greenway Parkway
Scottsdale, AZ 85254

Click Here to Book

Room Rate: $295/night plus tax
Rate expires: 3-16-2022
Room Reservation Phone: (480) 624-1000

CMHC Sponsors & Partners

Join this year’s illustrious lineup of brand partners and take your 2022 goals to the next level.

Download Prospectus

Click Here to Inquire

Conference Overview

Great Debates in Cardiometabolic Medicine:

CMHC Spring 2022

World-renowned experts will present on the latest developments in cardiovascular disease, chronic kidney disease, obesity & lifestyle, type 2 diabetes, lipids, and more.

What to Expect

Conference Chairs & SPC

Conference Faculty

Conference Agenda

Event Registration

Conference Venue

The Westin Kierland Resort & Spa

CMHC Sponsors & Partners

Subscribe to "The Monthly Beat" Newsletter

Quick Links

Professional Education

Connect

QUICK LINKS

Professional Education

Industry Resources

Subscribe